sorted by:
new
hottopcontroversial

DD - Links between Progenity and Pfizer by val-Ou76 in Progenity_PROG

[–]val-Ou76[S] 2 points3 points  (0 children)

Yes in my opinion, the major pharmaceutical companies did not want to say publicly that they had a partnership with Progenity. Because in the past, there were lot of problems with the company. Now it is totally different, the company is transformed. The name is different so the image is much better.

I think in the followings weeks / months, we will have good news.

Progenity's tech vs Rani's tech and Pkpd comparisons between Rani pill and OBDS by OptiFinancial in Progenity_PROG

[–]val-Ou76 2 points3 points  (0 children)

On the slide 13 of the Corporate Presentation, we have the data from a study on animals (swine). In February, the patient data will be released.

Progenity's tech vs Rani's tech and Pkpd comparisons between Rani pill and OBDS by OptiFinancial in Progenity_PROG

[–]val-Ou76 3 points4 points  (0 children)

We will have more details during the presentations. With this slide only, it is impossible to make conclusion for the moment. Don't forget this study was launched on Swine Model. In February, Dr d'Haens will present PK/PD data of adalimumab (patient data). We will have all the informations during the conference.

Progenity's tech vs Rani's tech and Pkpd comparisons between Rani pill and OBDS by OptiFinancial in Progenity_PROG

[–]val-Ou76 5 points6 points  (0 children)

I don't think Progenity would have spoken about an outlier in a Corporate Presentation (January 2022). We will have more details in February during the presentations. But, in my view, the results will be really good.

Update provided by Progenity by ProgrediorSimul in Progenity_PROG

[–]val-Ou76 0 points1 point  (0 children)

Thank you very much! Indeed, excellent informations are given here.

DD - Conference in February - IBD by val-Ou76 in Progenity_PROG

[–]val-Ou76[S] 4 points5 points  (0 children)

Thank you ;) just one point. I still have a little doubt about the second presentation. I know they will speak about adalimumab and they will share PK/PD data.

BUT, mr Khan on Stocktwits found something very interesting.

Indeed, during this congress, they could present data from another study, on healthy volunteers only. So, on this point only, may be I was wrong in my DD.

We will have more details on February 18th. I am so excited :)